Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 303: 123268, 2023 Dec 15.
Article in English | MEDLINE | ID: mdl-37597354

ABSTRACT

This study aims to quantify ciprofloxacin in commercial tablets with varying excipient compositions using Fourier Transform Near-Infrared Spectroscopy (FT-NIR) and chemometric models: Partial Least Squares (PLS) and Multivariate Curve Resolution - Alternating Least Squares (MCR-ALS). Matrix variation, arising from differences in excipient compositions among the tablets, can impact quantification accuracy. We discuss this phenomenon, emphasizing potential issues introduced by varying certain excipients and its importance in reliable ciprofloxacin quantification. We evaluated the performance of PLS and MCR-ALS models independently on two sets of tablets, each containing the same drug substance but different excipients. The statistical results revealed promising results with PLS prediction error of 0.38% w/w of the first set and 0.47% w/w of the second set, while MCR-ALS achieved prediction errors of 0.67% w/w of the first set and 1.76% w/w of the second set. To address the challenge of matrix variation, we developed single models for PLS and MCR-ALS using a dataset combining both first and second sets. The PLS single model demonstrated a prediction error of 4.3% w/w and a relative error of 6.41% w/w, while the MCR-ALS single model showed a prediction error of 1.88% w/w and a relative error of 1.29% w/w. We then assessed the performance of the single PLS and MCR-ALS models developed based on the combination of the first and the second set in quantifying ciprofloxacin in various commercial tablet brands containing new excipients. The PLS model achieved a prediction error ranging between 6.2% w/w and 8.39% w/w, with relative errors varied between 8.53% w/w and 12.82% w/w. On the other hand, the MCR-ALS model had a prediction error between 1.11% w/w and 2.66% w/w, and the relative errors ranging from 0.8% to 1.74% w/w.


Subject(s)
Chemometrics , Excipients , Least-Squares Analysis , Ciprofloxacin , Spectroscopy, Fourier Transform Infrared
2.
Talanta ; 207: 120306, 2020 Jan 15.
Article in English | MEDLINE | ID: mdl-31594606

ABSTRACT

Handheld Raman spectroscopy is actually booming. Recent devices improvements aim at addressing the usual Raman spectroscopy issues: fluorescence with shifted-excitation Raman difference spectroscopy (SERDS), poor sensitivity with surface enhanced Raman scattering (SERS) and information only about the sample surface with spatially offset Raman spectroscopy (SORS). While qualitative performances of handheld devices are generally well established, the quantitative analysis of pharmaceutical samples remains challenging. The aim of this study was to compare the quantitative performances of three commercially available handheld Raman spectroscopy devices. Two of them (TruScan and IDRaman mini) are equipped with a 785 nm laser wavelength and operate in a conventional backscattering mode. The IDRaman has the Orbital Raster Scanning (ORS) option to increase the analyzed surface. The third device (Resolve) operates with an 830 nm laser wavelength both in backscattering and in SORS modes. The comparative study was carried out on ibuprofen-mannitol-microcrystalline cellulose ternary mixtures. The concentration of ibuprofen ranged from 24 to 52% (w/w) while the proportions of the two excipients were varied to avoid cross-correlation as much as possible. Analyses were performed either directly through a glass vial or with the glass vial in an opaque polypropylene flask, using a validated FT-NIR spectroscopy method as a reference method. Chemometric analyses were carried out with the Partial Least Squares Regression (PLS-R) algorithm. The quantitative models were validated using the total error approach and the ICH Q2 (R1) guidelines with ±â€¯15% as acceptance limits.


Subject(s)
Pharmaceutical Preparations/analysis , Product Packaging , Spectrophotometry/instrumentation , Spectrum Analysis, Raman/instrumentation , Glass , Ibuprofen/analysis , Polypropylenes
3.
Ann Pharm Fr ; 75(6): 446-454, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28797469

ABSTRACT

According to the Food and Drug Administration and the European Good Manufacturing Practices (GMP) guidelines, Annual Product Review (APR) is a mandatory requirement in GMP. It consists of evaluating a large collection of qualitative or quantitative data in order to verify the consistency of an existing process. According to the Code of Federal Regulation Part 11 (21 CFR 211.180), all finished products should be reviewed annually for the quality standards to determine the need of any change in specification or manufacturing of drug products. Conventional Statistical Process Control (SPC) evaluates the pharmaceutical production process by examining only the effect of a single factor at the time using a Shewhart's chart. It neglects to take into account the interaction between the variables. In order to overcome this issue, Multivariate Statistical Process Control (MSPC) can be used. Our case study concerns an APR assessment, where 164 historical batches containing six active ingredients, manufactured in Morocco, were collected during one year. Each batch has been checked by assaying the six active ingredients by High Performance Liquid Chromatography according to European Pharmacopoeia monographs. The data matrix was evaluated both by SPC and MSPC. The SPC indicated that all batches are under control, while the MSPC, based on Principal Component Analysis (PCA), for the data being either autoscaled or robust scaled, showed four and seven batches, respectively, out of the Hotelling T2 95% ellipse. Also, an improvement of the capability of the process is observed without the most extreme batches. The MSPC can be used for monitoring subtle changes in the manufacturing process during an APR assessment.


Subject(s)
Drug Industry/statistics & numerical data , Drug Industry/standards , Multivariate Analysis , Pharmaceutical Preparations/standards , Quality Control , Chromatography, High Pressure Liquid , Morocco , Principal Component Analysis
4.
Ann Pharm Fr ; 75(2): 112-120, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27692351

ABSTRACT

Many different assaying high performance thin layer chromatography (HPTLC) methods have been developed and validated in order to be used in routine analysis in different analytical fields. Validation often starts by the evaluation of the linearity of the calibration curve. Frequently, if the correlation coefficient is close to one, the linear calibration curve model is considered to be proper to predict the unknown concentration in the sample. But is this simple model effective to assess the behavior of the response of an HPTLC method as a function of concentration. To answer this question, a method for the determination of azithromycin by HPTLC has been developed and validated following both the classical approach and that based on the accuracy profile. Silica gel plates with fluorescence indicator F254 and chloroform - ethanol - 25% ammonia 6:14:0.2 (v/v/v) as mobile phase were used. Analysis was carried out in reflectance mode at 483nm. The RF of azithromycin was 0.53. The validation based on the classical approach, shows that the behavior is not linear, even though r2=0.999 because the lack of fit test is significant (P<0.05). Validation based on the accuracy profile approach considering both the straight line and the quadratic regression model, show that the former results is a ß-expectation tolerance interval outside the acceptance limits, while with the latter, this interval is within the limits of ±5% acceptability for a range which extends from 0.2 to 1.0µg/zone. With the quadratic model, the method showed to be precise and accurate.


Subject(s)
Anti-Bacterial Agents/analysis , Azithromycin/analysis , Calibration , Chromatography, Thin Layer , Drug Compounding , Fluorescent Dyes , Indicators and Reagents , Reproducibility of Results
5.
Odontostomatol Trop ; 37(146): 42-8, 2014 Jun.
Article in French | MEDLINE | ID: mdl-25223146

ABSTRACT

The aim of our study was to determine fluorides (F-) content in the well water consumed as drinking water by some Moroccan populations in rural areas. All samples were collected between April and October 2011. Measurements were performed by an ion selective electrode. Thirty wells spread to cover most of the country and locally chosen based on the number of inhabitants who consume its water. All wells were in rural areas. The mean (+/- SD) of F- was 1.84 +/- 1.6 mg/L with a range from 0.42 to 8.95 mg/L Concentrations of F- in phosphate regions were higher than those found in other regions. More than half of the samples exceeded the current standard. Our study showed that water of some Moroccan regions is naturally rich in F-exposing people who consume it at high risk of fluorosis.


Subject(s)
Cariostatic Agents/analysis , Fluorides/analysis , Rural Population , Water Supply/analysis , Water Wells/analysis , Cross-Sectional Studies , Humans , Ion-Selective Electrodes , Micropore Filters , Morocco , Phosphates/analysis , Potentiometry , Seasons , Sodium Fluoride/analysis
6.
Ann Pharm Fr ; 72(4): 244-55, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24997886

ABSTRACT

A simple, rapid, and sensitive RP-HPLC method using photodiode array detection was developed and validated for the simultaneous determination of butylhydroxyanisol and simvastatin with its impurities in tablet forms. Chromatographic separation was achieved on a Phenomenex Hypersil (250×4.6 mm, 5 µm) column using the mobile phase acetonitrile-sodium acetate (12 mM) buffered to 4.2 with glacial acetic acid. The flow rate was 1.7 mL/min, and the UV detection were made at 238 nm for simvastatin and its impurities and at 290 nm for butylhydroxyanisol. The system suitability solution used for peak impurity identification was generated in-situ without use of any impurity reference standard. The method was validated according to ICH Q2(R1) guidelines, and the acceptance criteria for accuracy, precision, linearity, specificity, robustness, LOD, and LOQ, were met in all cases. Moreover, the reproducibility results obtained by 22 Official Medicines Control Laboratories (OMCL) of European Directorate were satisfactory. The compounds selected for impurity validation were based on those found during long term and accelerate stability studies carried out on several formulation tablets from Moroccan and other markets. The described method was robust and successfully applied in quality control laboratories for routine analysis to determine the butylhydroxyanisol and simvastatin with its impurities content in tablet dosage forms.


Subject(s)
Butylated Hydroxyanisole/analysis , Chromatography, High Pressure Liquid/methods , Drug Contamination , Hydroxymethylglutaryl-CoA Reductase Inhibitors/analysis , Simvastatin/analysis , Drug Stability , Limit of Detection , Quality Control , Reference Standards , Reproducibility of Results , Spectrophotometry, Ultraviolet , Tablets/analysis
7.
Odontostomatol Trop ; 35(138): 15-20, 2012 Jun.
Article in French | MEDLINE | ID: mdl-22988787

ABSTRACT

INTRODUCTION: Dental caries represents a problem of public health in Morocco and the reduction of this pathology is a priority of the Ministry of Health. The use of fluoride toothpastes is, at present, recognized as being an effective means for the prevention of dental caries. MATERIAL AND METHODS: [corrected] The aim of our study was to verify the correspondence of the information marked on packagings with the international standards, but also to determine using potentiometry the quantity of fluorine presents in toothpastes marketed in Morocco from three origins: pharmacies, hypermarkets and ambulant sellers. RESULTS: The study concerned 56 toothpastes, 73.2% of toothpastes respect the standards of the concerning WHO dates of manufacturing and lapsing. The type of fluoride was specified only on 67.8% of packagings and the used concentration of fluoride was indicated only in 62.5% of the tested samples. For 56 studied toothpastes, the results revealed that if we take into account standards recommended by the WHO and the European Union, only 57.1% of toothpastes could have an effect dental caries. CONCLUSION: The results of this study show that there is a real need of quality control of fluoride toothpastes sold in Morocco especially those of the itinerant market.


Subject(s)
Fluorides/analysis , Toothpastes/chemistry , Toothpastes/standards , Drug Labeling , European Union , Ion-Selective Electrodes , Marketing , Morocco , Potentiometry , World Health Organization
8.
Drug Test Anal ; 4(12): 1014-27, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22615163

ABSTRACT

An innovative versatile strategy using Total Error has been proposed to decide about the method's validity that controls the risk of accepting an unsuitable assay together with the ability to predict the reliability of future results. This strategy is based on the simultaneous combination of systematic (bias) and random (imprecision) error of analytical methods. Using validation standards, both types of error are combined through the use of a prediction interval or ß-expectation tolerance interval. Finally, an accuracy profile is built by connecting, on one hand all the upper tolerance limits, and on the other hand all the lower tolerance limits. This profile combined with pre-specified acceptance limits allows the evaluation of the validity of any quantitative analytical method and thus their fitness for their intended purpose. In this work, the approach of accuracy profile was evaluated on several types of analytical methods encountered in the pharmaceutical industrial field and also covering different pharmaceutical matrices. The four studied examples depicted the flexibility and applicability of this approach for different matrices ranging from tablets to syrups, different techniques such as liquid chromatography, or UV spectrophotometry, and for different categories of assays commonly encountered in the pharmaceutical industry i.e. content assays, dissolution assays, and quantitative impurity assays. The accuracy profile approach assesses the fitness of purpose of these methods for their future routine application. It also allows the selection of the most suitable calibration curve, the adequate evaluation of a potential matrix effect and propose efficient solution and the correct definition of the limits of quantification of the studied analytical procedures.


Subject(s)
Models, Statistical , Pharmaceutical Preparations/analysis , Technology, Pharmaceutical/methods , Amoxicillin/analysis , Bias , Calibration , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid , Dosage Forms , Drug Contamination , Fluconazole/analysis , Limit of Detection , Linear Models , Metformin/analysis , Parabens/analysis , Reference Standards , Reproducibility of Results , Spectrophotometry, Ultraviolet , Technology, Pharmaceutical/standards
9.
Anal Chim Acta ; 714: 47-56, 2012 Feb 10.
Article in English | MEDLINE | ID: mdl-22244136

ABSTRACT

Analytical methods capability evaluation can be a useful methodology to assess the fitness of purpose of these methods for their future routine application. However, care on how to compute the capability indices have to be made. Indeed, the commonly used formulas to compute capability indices such as Cpk, will highly overestimate the true capability of the methods. Especially during methods validation or transfer, there are only few experiments performed and, using in these situations the commonly applied capability indices to declare a method as valid or as transferable to a receiving laboratory will conduct to inadequate decisions. In this work, an improved capability index, namely Cpk-tol and the corresponding estimator of proportion of non-conforming results (π(Cpk-tol)) have been proposed. Through Monte-Carlo simulations, they have been shown to greatly increase the estimation of analytical methods capability in particular in low sample size situations as encountered during methods validation or transfer. Additionally, the usefulness of this capability index has been illustrated through several case studies covering applications commonly encountered in the pharmaceutical industry. Finally a methodology to determine the optimal sample size required to validate analytical methods is also given using the proposed capability metric.


Subject(s)
Chemistry Techniques, Analytical/methods , Chemistry Techniques, Analytical/standards , Pharmaceutical Preparations/analysis , Validation Studies as Topic , Acetazolamide/analysis , Chromatography, Liquid/methods , Computer Simulation , Drug Industry/methods , Drug Industry/standards , Drug Industry/trends , Fluconazole/analysis , Monte Carlo Method , Reproducibility of Results , Tablets/chemistry
10.
Ann Trop Med Parasitol ; 105(6): 447-53, 2011 Sep.
Article in English | MEDLINE | ID: mdl-22117854

ABSTRACT

Malaria is the biggest killer of African children, yet it is cheaply preventable and curable with insecticides spraying, impregnated bednets and effective drugs. This study aimed to evaluate the quality of Chloroquine (CQ) tablets available in selected African countries. Twenty-six samples of antimalarial CQ tablet of 100, 150 and 250 mg were collected from 12 African countries and evaluated for their quality in the Drugs Quality Control Laboratory of Rabat, Morocco. The identification and dosage of active pharmaceutical ingredients in the tablets, dissolution rate, hardness and the friability of CQ tablets were performed according to the United States Pharmacopeia (USP) and European Pharmacopoeia (Eur.Ph.) recommended methods. The results showed that 7·7% of the sampled CQ tablets available in Burkina Faso were of low quality. Failure in dissolution profile was found in 50% of CQ tablets sampled from Benin, Burkina Faso, Comoros Union, Mali and Senegal. The findings showed poor quality of CQ tablets available in the African market. This problem may affect the efforts to control malaria in Africa. Efficient regulatory systems of drugs quality control should be implemented.


Subject(s)
Antimalarials/standards , Chloroquine/standards , Africa , Antimalarials/administration & dosage , Antimalarials/chemistry , Chloroquine/administration & dosage , Chloroquine/chemistry , Drug Compounding/standards , Hardness Tests/methods , Humans , Pilot Projects , Product Surveillance, Postmarketing/methods , Quality Control , Solubility , Tablets/standards
11.
J Pharm Biomed Anal ; 55(5): 1208-12, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21466938

ABSTRACT

The aim of the present study was to develop near infrared (NIR) and X-ray powder diffraction methods (XRPD) able to determine pure crystalline form II of fluconazole in a binary polymorphic mixtures containing forms II and III. In order to give a first performance estimation of both methods, these latters were pre-validated using accuracy profiles, a statistical approach based on ß-expectation tolerance intervals. Both methods showed a good trueness, precision and accuracy and their ß-expectation tolerance intervals were fully included within the acceptance limits. The comparative study was carried out using statistical analysis based on the work of Bland and Altman. A good agreement between the two methods was demonstrated indicating the interchangeability of NIR method with XRPD method.


Subject(s)
Chemistry, Pharmaceutical/methods , Fluconazole/analysis , Spectroscopy, Near-Infrared/methods , X-Ray Diffraction/methods , Calibration , Chemistry Techniques, Analytical , Crystallization , Models, Chemical , Models, Statistical , Powders , Regression Analysis , Reproducibility of Results , Technology, Pharmaceutical/methods
12.
J Pharm Biomed Anal ; 55(3): 583-90, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-21377822

ABSTRACT

Analytical methods validation is a mandatory step to evaluate the ability of developed methods to provide accurate results for their routine application. Validation usually involves validation standards or quality control samples that are prepared in placebo or reconstituted matrix made of a mixture of all the ingredients composing the drug product except the active substance or the analyte under investigation. However, one of the main concerns that can be made with this approach is that it may lack an important source of variability that come from the manufacturing process. The question that remains at the end of the validation step is about the transferability of the quantitative performance from validation standards to real authentic drug product samples. In this work, this topic is investigated through three case studies. Three analytical methods were validated using the commonly spiked placebo validation standards at several concentration levels as well as using samples coming from authentic batch samples (tablets and syrups). The results showed that, depending on the type of response function used as calibration curve, there were various degrees of differences in the results accuracy obtained with the two types of samples. Nonetheless the use of spiked placebo validation standards was showed to mimic relatively well the quantitative behaviour of the analytical methods with authentic batch samples. Adding these authentic batch samples into the validation design may help the analyst to select and confirm the most fit for purpose calibration curve and thus increase the accuracy and reliability of the results generated by the method in routine application.


Subject(s)
Pharmaceutical Preparations/analysis , Pharmaceutical Preparations/standards , Placebos/analysis , Placebos/standards , Calibration , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid/instrumentation , Chromatography, High Pressure Liquid/methods , Hydrochlorothiazide/analysis , Hydrochlorothiazide/standards , Metformin/analysis , Metformin/standards , Parabens/analysis , Parabens/standards , Quality Control , Reference Standards , Reproducibility of Results , Spectrophotometry, Ultraviolet/instrumentation , Spectrophotometry, Ultraviolet/methods , Tablets , Tetrazoles/analysis , Tetrazoles/standards , Valine/analogs & derivatives , Valine/analysis , Valine/standards , Valsartan
13.
J Chromatogr A ; 1217(19): 3180-92, 2010 May 07.
Article in English | MEDLINE | ID: mdl-19733857

ABSTRACT

Analytical method validation is a mandatory step at the end of the development in all analytical laboratories. It is a highly regulated step of the life cycle of a quantitative analytical method. However, even if some documents have been published there is a lack of clear guidance for the methodology to follow to adequately decide when a method can be considered as valid. This situation has led to the availability of several methodological approaches and it is therefore the responsibility of the analyst to choose the best one. The classical decision processes encountered during method validation evaluation are compared, namely the descriptive, difference and equivalence approaches. Furthermore a validation approach using accuracy profile computed by means of beta-expectation tolerance interval and total measurement error is also available. In the present paper all of these different validation approaches were applied to the validation of two analytical methods. The evaluation of the producer and consumer risks by Monte Carlo simulations were also made in order to compare the appropriateness of these various approaches. The classical methodologies give rise to inadequate and contradictory conclusions which do not allow them to answer adequately the objective of method validation, i.e. to give enough guarantees that each of the future results that will be generated by the method during routine use will be close enough to the true value. It is found that the validation methodology which gives the most guarantees with regards to the reliability or adequacy of the decision to consider a method as valid is the one based on the use of the accuracy profile.


Subject(s)
Chemistry, Analytic , Models, Statistical , Acetaminophen/analysis , Calibration , Chromatography, Liquid/methods , Codeine/analysis , Computer Simulation , Linear Models , Loratadine/analysis , Reproducibility of Results , Research Design , Validation Studies as Topic
14.
J Chromatogr B Analyt Technol Biomed Life Sci ; 877(23): 2214-23, 2009 Aug 01.
Article in English | MEDLINE | ID: mdl-19144574

ABSTRACT

The transfer of a method from a laboratory to a production site is an important step in the development cycle of new pharmaceutical products. Method transfers are increasingly implemented due to the economical pressure coming from the rationalization of production sites, analytical subcontracting and fusion of pharmaceutical groups. However, no official guidance regarding study design, data analysis, or decision procedures is present neither in FDA documents nor in ICH documents for method transfers. The experiments performed in such a transfer and the methodology used to accept or reject it should be fitted for purpose. In order to provide to analysts a global view of the problematic of analytical method transfer, this paper reviews the documentation available in the scientific literature about the design of transfer studies and the required sample size. Special focus is also made on the statistical methodologies available for decision making with particular emphasis on risk management. Examples of transfer of pharmaceutical, bio-pharmaceutical and biological methods published in the literature are reviewed in order to illustrate the various possibilities among the strategies for methods transfer.


Subject(s)
Chemistry, Analytic , Guidelines as Topic , Research Design , Technology Transfer , Chemistry, Analytic/legislation & jurisprudence , Chemistry, Analytic/standards , Research Design/legislation & jurisprudence , Research Design/standards , Technology, Pharmaceutical/legislation & jurisprudence , Technology, Pharmaceutical/standards , United States
15.
Food Addit Contam ; 24(3): 285-91, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17364931

ABSTRACT

One hundred samples of dried fruits (20 dried raisins, 20 walnuts, 20 peanuts, 20 dried figs and 20 pistachios) and 20 samples of rice purchased from retail shops in the Rabat and Salé area in Morocco were analysed for ochratoxin A (OTA) by immunoaffinity clean-up (IAC) and liquid chromatography (LC) with fluorescence detection. The limit of quantification (LOQ) (S/N = 10:1) of OTA was 0.02 ng g(-1) in rice, 0.03 ng g(-1) in pistachio, peanut and walnut, and 0.03 ng g(-1) in dried raisins and dried figs. The incidences of occurrence of OTA in dried raisins, walnuts, peanuts, dried figs and rice were 30, 35, 25, 65 and 90%, respectively. Analytical results showed that pistachio samples contained no detectable OTA, but concentrations ranged from 0.02 +/- 0.01 to 32.4 +/- 2.10 ng g(-1) in rice, from 0.10 +/- 0.05 to 2.36 +/- 0.75 in peanut, from 0.03 +/- 0.01 to 1.42 +/- 0.45 in dried figs, from 0.05 +/- 0.02 to 4.95 +/- 0.02 in dried raisins, and from 0.04 +/- 0.01 to 0.23 +/- 0.05 in walnuts. The results also showed that 15% of the total number of rice samples analysed exceeded the 2002 regulatory limit set by European Union regulations for cereals. This is the first report on the occurrence of OTA in dried fruits and rice available in Morocco.


Subject(s)
Food Contamination/analysis , Fruit/chemistry , Ochratoxins/analysis , Oryza/chemistry , Carcinogens/analysis , Chromatography, Liquid/methods , Food Analysis/methods , Humans , Morocco , Mycotoxins/analysis , Nuts/chemistry
16.
J Pharm Biomed Anal ; 44(3): 640-51, 2007 Jul 27.
Article in English | MEDLINE | ID: mdl-17010553

ABSTRACT

A robustness test of a capillary electrophoresis method for the chiral separation of timolol in nonaqueous acidified media was performed. A two-level Plackett-Burman design was applied in which one qualitative and six quantitative factors were examined. Resolution, migration times and relative migration times to pyridoxine (selected as internal standard) were examined as qualitative responses to evaluate electrophoretic performance. A quantitative response, the content of R-timolol in S-timolol maleate sample, was also considered. Even though some significant factor effects were observed on the qualitative responses, it was still possible to quantify the R-timolol in the S-timolol maleate samples properly. The quantitative response was not significantly affected by the selected factors, demonstrating the robustness of the procedure. However, the use of different HDMS-beta-CD batches seemed to affect both types of responses necessitating to introduce a warning in the procedure. Since the experiments of the Plackett-Burman design can be assimilated to laboratories in an interlaboratory study, uncertainty can be evaluated using the robustness test data. The robustness test was set-up in such a way that the required variances could be estimated.


Subject(s)
Adrenergic beta-Antagonists/analysis , Electrophoresis, Capillary/methods , Technology Transfer , Timolol/analysis , Drug Contamination , Reference Standards , Reproducibility of Results , Stereoisomerism , Uncertainty
17.
Med Mal Infect ; 36(7): 386-9, 2006 Jul.
Article in French | MEDLINE | ID: mdl-16842953

ABSTRACT

UNLABELLED: Metallo-beta-lactamases (MBL) are enzymes produced by Gram-negative bacilli such as Pseudomonas aeruginosa and Acinetobacter baumannii. These enzymes make these isolates resistant to imipenem. AIM: The aim of this study was to determine the prevalence of this resistance mechanism in Pseudomonas aeruginosa and Acinetobacter baumannii strains identified in the bacteriology laboratory of the Rabat Ibn Sina teaching hospital, Morocco. MATERIALS AND METHOD: Screening for MBL was systematic in all resistant strains and/or strains with decreased sensitivity to imipenem, according to Dongeun Yong et al.'s method, using a sterilized solution of EDTA 0.5 M pH 8. RESULTS: Eighty-five bacterial strains (48 P. aeruginosa and 37 A. baumannii) were identified 23% (11) and 57% (21) of which were respectively resistant to the imipenem. The prevalence of MbetaL producing strains was 27% for P. aeruginosa and 38% for A. baumannii. CONCLUSION: These results show that the frequency of these strains is increases in our hospital and that their emergence represents a serious therapeutic and epidemiological problem. This means that we need to implement the supervision of hospital microbial environment and strictly apply hygiene measures.


Subject(s)
Acinetobacter/isolation & purification , Imipenem/pharmacology , Pseudomonas aeruginosa/isolation & purification , beta-Lactamases/metabolism , Acinetobacter/drug effects , Acinetobacter/enzymology , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/enzymology
18.
Talanta ; 38(8): 929-35, 1991 Aug.
Article in English | MEDLINE | ID: mdl-18965239

ABSTRACT

A new polymer matrix based membrane electrode with an ion-exchanger responding to calcium was constructed by dissolving the copolymer ethylene-vinyl-acetate together with the ion-exchanger in chloroform in the presence of a mixture of dioctylphthalate-nitrobenzene as plasticizer. The ion-exchanger used as the electroactive component was calcium didecyl phosphate in di-(n-octylphenyl) phosphonate (Orion). This electrode exhibited near-Nernstian response over the concentration range 10(-1)-4 x 10(-6)M calcium. The pH did not affect the electrode performance within the range 8-11. Response time varied from 15 to 120 sec and the lifetime exceeded six months. The membrane is subject to static charge buildup, but this is avoided by controlling the level of dryness of the membrane. Selectivity coefficients determined for both monovalent and divalent cations showed negligible interference by most of these ions. The electrode was applied successfully to the determination of calcium in commercial mineral waters.

19.
J Pharm Biomed Anal ; 9(5): 393-9, 1991.
Article in English | MEDLINE | ID: mdl-1932274

ABSTRACT

New polymeric electrodes responding to the cationic forms of tetracaine (TC), lidocaine (LD), and procaine (PC) were constructed by incorporating their ion-pair complexes (the salts of TC, LD and PC with phosphotungstic acid) into ethylene-vinyl acetate (E/VAC) copolymer. Other ion pairing agents investigated were silicotungstate and tetraphenylborate. The phosphotungstic acid resulted in the best linear and Nernstian response. A 1:1 (v/v) mixture of dioctyl phthalate (DOP) and nitrobenzene (NB) was used as plasticizer. The electrodes exhibited linear response over the concentration ranges 10(-2)-5.6 x 10(-6), 10(-2)-2.5 x 10(-5) and 10(-2)-1.8 x 10(-5) M of TC, LD and PC, respectively. pH did not affect the electrode performances within the ranges 2.7-6.3, 2.6-6.7 and 2.8-7.5 for the three electrodes, respectively. Interferences are negligible for many organic base and alkali metal cations. Cations of similar structure interfere with LD and PC, but not appreciably with TC. Direct potentiometry was used to determine these compounds in pharmaceutical preparations with accurate results.


Subject(s)
Lidocaine/analysis , Procaine/analysis , Tetracaine/analysis , Electrodes , Hydrogen-Ion Concentration , Plasticizers , Potentiometry/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...